Improving Door-to-Needle Times A Single Center Validation of the Target Stroke Hypothesis

被引:39
|
作者
Ruff, Ilana M. [1 ]
Ali, Syed F. [1 ]
Goldstein, Joshua N. [3 ]
Lev, Michael [2 ]
Copen, William A. [2 ]
McIntyre, Joyce [3 ]
Rost, Natalia S. [1 ]
Schwamm, Lee H. [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Emergency Med, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
stroke; thrombolytic therapy; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INTRAVENOUS THROMBOLYSIS; NOTIFICATION; ASSOCIATION; ALTEPLASE; MINUTES; THERAPY;
D O I
10.1161/STROKEAHA.113.004073
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose National guidelines recommend imaging within 25 minutes of emergency department arrival and intravenous tissue-type plasminogen activator within 60 minutes of emergency department arrival for patients with acute stroke. In 2007, we implemented a new institutional acute stroke care model to include 10 best practices and evaluated the effect of this intervention on improving door-to-computed tomography (CT) and door-to-needle (DTN) times at our hospital. Methods We compared patients who presented directly to our hospital with acute ischemic stroke in the preintervention (2003-2006) and postintervention (2008-2011) periods. We did not include 2007, the year that the new protocol was established. Predictors of DTN 60 minutes before and after the intervention were assessed using (2) for categorical variables, and t test and Wilcoxon signed-rank test for continuous variables. Results Among 2595 patients with acute stroke, 284 (11%) received intravenous tissue-type plasminogen activator. For patients arriving within an intravenous tissue-type plasminogen activator window, door-to-CT <25 improved from 26.7% pre intervention to 52.3% post intervention (P<0.001). Similarly, the percentage of patients with DTN <60 doubled from 32.4% to 70.3% (P<0.001). Patients with DTN 60 did not differ significantly with respect to demographics, comorbidities, or National Institutes of Health Stroke Scale score in comparison with those treated after 60 minutes. Conclusions Door-to-CT and DTN times improved dramatically after applying 10 best practices, all of which were later incorporated into the Target Stroke Guidelines created by the American Heart Association. The only factor that significantly affected DTN60 was the intervention itself, indicating that these best practices can result in improved DTN times.
引用
收藏
页码:504 / 508
页数:5
相关论文
共 50 条
  • [1] Improving Door-to-Needle Times with Target Stroke
    Ruff, Ilana M.
    Syed, Ali
    Rost, Natalia
    Goldstein, Joshua
    Lev, Michael
    Copen, William
    McIntyre, Joyce
    Schwamm, Lee
    [J]. STROKE, 2013, 44 (02)
  • [2] Impact of Target Stroke on Reducing Door-to-Needle Times
    Moore, Kari
    Liu, Ruolan
    Bays, Cathy
    Bystrek, Laura
    Cochrane, Betty
    Wise, Elizabeth
    Remmel, Kerri
    [J]. STROKE, 2013, 44 (02)
  • [3] How to half door-to-needle times: A single center strategy
    Demeestere, J.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 126 - 127
  • [4] Stroke Door-to-Needle Target of 30 Minutes or Less: A Single Center Experience.
    Fuhrman, Susan
    Lazarro, Marc
    [J]. STROKE, 2019, 50
  • [5] What Changes Improve Door-to-Needle Times? Results From a Single Center Door-to-Needle Improvement Initiative
    Kamal, Noreen
    Hill, Michael D.
    Stephenson, Caroline
    Demchuk, Andrew M.
    Holodinsky, Jessalyn K.
    Zerna, Charlotte
    Bugbee, Erin
    Vilneff, Renee
    Kashyap, Devika
    Smith, Eric E.
    [J]. STROKE, 2016, 47
  • [6] Improving Door-to-Needle Times in Acute Ischemic Stroke: Interim Fundings From Target: Stroke Phase II
    Fonarow, Gregg C.
    Cox, Margueritte
    Smith, Eric E.
    Saver, Jeffery L.
    Reeves, Mathew J.
    Bhatt, Deepak L.
    Suter, Robert
    Schulte, Philip J.
    Xian, Ying
    Hernandez, Adrian F.
    Peterson, Eric D.
    Schwamm, Lee H.
    [J]. STROKE, 2016, 47
  • [7] IMPROVING DOOR-TO-NEEDLE TIMES WITH CLINICAL PHARMACISTS AS MEMBERS OF THE STROKE RESPONSE TEAM
    Goddard, Kara
    Chester, Katleen Wyatt
    [J]. CRITICAL CARE MEDICINE, 2012, 40 (12) : U111 - U111
  • [8] Thrombolysis: Improving door-to-needle times for ischemic stroke treatment - A narrative review
    Kamal, Noreen
    Smith, Eric E.
    Jeerakathil, Thomas
    Hill, Michael D.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2018, 13 (03) : 268 - 276
  • [9] Door-to-needle times in acute stroke clinical trials
    Llanes, JN
    Kidwell, CS
    Starkman, S
    Leary, MC
    Eckstein, M
    Saver, JL
    [J]. NEUROLOGY, 2001, 56 (08) : A436 - A436
  • [10] Is Target Stroke Initiative Effective in Reducing Door-To-Needle Times in All Size Hospitals?
    Jones, Peggy
    O'Neill, Kathleen
    Scharnott, MIchelle
    Prabhakaran, Shyam
    [J]. STROKE, 2016, 47